Canakinumab Subcutaneous and Hematinic with Folic Acid
Determining the interaction of Canakinumab Subcutaneous and Hematinic with Folic Acid and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: ferrous fumarate / folic acid
Brand name: Ed Cyte F, Hematinic with Folic Acid, Hemocyte-F, Ferrocite F, Nephro-Fer RX, Equi-Cyte F, Ircon-FA, Drysol, Hypercare, Xerac AC
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Hematogen FA Capsules
- Canakinumab Subcutaneous-Hematogen Forte
- Canakinumab Subcutaneous-Hematogen Softgels
- Canakinumab Subcutaneous-Hematron
- Canakinumab Subcutaneous-Hemax
- Canakinumab Subcutaneous-Heme iron polypeptide
- Hematinic with Folic Acid-Canasa
- Hematinic with Folic Acid-Canasa Pac rectal
- Hematinic with Folic Acid-Canasa rectal
- Hematinic with Folic Acid-Cancidas
- Hematinic with Folic Acid-Candesartan
- Hematinic with Folic Acid-Candesartan and Hydrochlorothiazide